Ingelvac AR4 (Canada)

Manufacturer: Boehringer

Bordetella Bronchiseptica-Pasteurella Multocida Bacterin-Toxoid

Veterinary Use Only

Ingelvac AR4 Indications

For use as an aid in the prevention against atrophic rhinitis caused by Bordetella bronchiseptica and Pasteurella multocida Type D in healthy swine.

Composition

Chemically inactivated and detoxified swine isolates of toxigenic Bordetella bronchiseptica and toxigenic Pasteurella multocida Type D. Preservative: Gentamicin.

Dosage

Sows and Gilts: Using aseptic technique, inject 2 mL intramuscularly 5 weeks prior to farrowing. Repeat with a second 2 mL dose 2 to 3 weeks prior to farrowing. Administer one 2 mL dose 2 to 3 weeks prior to each subsequent farrowing.

Piglets: Should receive colostrum from vaccinated sow as soon as possible after birth. In 1 to 3 day old pigs, inject 1 mL intramuscularly or subcutaneously using aseptic technique.

Ingelvac AR4 Caution

Store in dark at 2°-7°C. Avoid freezing. Shake well. Use entire contents when first opened. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur.

Antidote

Epinephrine.

Boehringer Ingelheim Vetmedica, Inc., St. Joseph, Missouri 64506 U.s.a.

U.s. Veterinary License No. 124

Manufactured For: Boehringer Ingelheim (canada) Ltd., Burlington, Ontario L7l 5h4

100 mL

23106-04

Nac No.

12300231